Intelligent bio solutions inc. announces closing of private placement offering

New york, dec. 22, 2022 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (the “company”), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point of care, today announced that it has closed a regulation s private placement (the “transaction”) for expected aggregate gross proceeds of $220,585.
INBS Ratings Summary
INBS Quant Ranking